LATEST NEWS AND EVENTS

In memory of Sanjiv Sam Gambhir, a leader in the development of precision oncology

Molecular imaging pioneer Sanjiv Sam Gambhir, MD, PhD, passed away on Saturday, July 18, from cancer. He was 57. From the earliest days of his...

Another milestone for the Oncidium foundation

Another milestone for the Oncidium foundation: 200 registered hospitals and counting! Thank you to all the nuclear medicine experts that registered their treatment center using...

The Oncidium foundation supports the SVIMS

In India, the Sri Venkateswara Institute of Medical Sciences (SVIMS), is a University Hospital based in Tirupati. The city is home to most famous...

Webinar Theranostics and PET Imaging Diagnostics

Webinar about the use of PET Imaging companion radiopharmaceutical in theranostics presented by 2 leading figures of nuclear medicine: Dr. Lisa Bodei, MD, PhD,...

SNMMI 2020 – Virtual Edition

Event: SNMMI 2020 Annual Meeting - Virtual Edition Date: 11-14 July 2020 The Oncidium foundation will be virtually attending and holding a booth. Find us under...

Atomic Nanogenerators in Targeted Alpha Therapy

Atomic in vivo nanogenerators such as actinium-225, thorium-227, and radium-223 are of increasing interest and importance in Targeted Alpha Therapy (TAT), in the treatment...

Postponing PRRT treatment during COVID 19

Postponing PRRT in Neuroendocrine tumors during COVID-19. What do you think? Check out the interesting responses of experts in the field. Read more >>

ProsTIC – The new Centre of Excellence

Congratulations Peter MacCallum Cancer Centre for the launch of The Prostate Theranostics & Imaging Centre of Excellence. ProsTIC will lead state-of-the-art research to deliver new...

TheraP Trial Design in Prostate Cancer

Interesting interview with Pr. Michael Hofman about TheraP Trial Design Evaluating 177Lu‐PSMA‐617 Theranostic Treatment vs Cabazitaxel in Progressive Metastatic Castration‐Resistant Prostate Cancer, where results are...

Prostate Cancer Theranostics – An Overview

The implementation of theranostic approaches to characterize and personalize patient management is beginning to be realized for prostate cancer patients. This review article summarized...

Theranostics continue to gain momentum

First article in collaboration with DOTmed.com, Inc. Discover more about how Radiotheranostics continue to gain momentum, by Richard Zimmermann, founder of the Oncidium foundation. " theranostics...

Oncidium Spring NEWSLETTER

Fresh news about Oncidium and Radiotheranostics, close up on Neuroendocrine Cancer UK, meet the Oncidium Ambassadors and much more! >> Discover the Newsletter  

Covid19 – Stay safe

Today, we would like to raise awareness of a different nature, equally important. We hope your relatives and you are well and healthy. The...

The Oncidium foundation goes live !

After six months of hard labor, research and discussions, welcome to the Oncidium’s new website! The entire website has been face-lifted in a user-friendly way...

World Cancer Day

The 4th of February is the World Cancer Day. Let's increase opportunities to build global awareness and impact-driven action. Keep strong, keep believing, keep...

EANM FOCUS MEETING – Theranostics for NET’s

Event: EANM FOCUS 3 - Molecular Imaging and Theranostics in Neuroendocrine tumours Date: Jan 30 - Feb 01, 2020 Location: Athens, Greece In-depth overview of the latest...

Radiolabeled PSMA PET for Renal Cancer

Promising results regarding the role of Radiolabeled PSMA PET as an imaging modality for the evaluation of widespread disease and response to target and...

How Radiotheranostics work?

Still wondering how Radiotheranostics work? Read this very interesting and accessible article by the International Atomic Energy Agency (IAEA):“It is a very efficient approach...

Strong potential of targeted α-therapy with 225Ac-PSMA-617

Targeted α-therapy with 225Ac-PSMA-617 although still preliminary, has demonstrated strong potential to significantly benefit advanced-stage prostate cancer patients. Dr. Machaba Michael Sathekge comments the...

Merry Christmas and Happy New Year

What a year! Looking back at 2019, we were able to start The Oncidium foundation activities, build a motivated team, meet wonderful dedicated people...

ARAB HEALTH 2020

Event: Arab Health 2020 Date: 27 - 30 January 2020 Location: UAE - Dubai World Trade Center

SNMICON 2019

Event: Oncidium Talk during SNMICOM Date: 14 December 2019 Time: 10.40-10.55 AM Location: Hall B, The Majestic The LaLit, Sahar Airport Rd, Mumbai, India

International Symposium Bad Berka 2019

Event: The Inauguration of the ICPO Foundation & The 20th Anniversary of Molecular Radiotherapy Date: 12-14 December 2019 Location: Zentralklink, Bad Berka

Happy Thanksgiving

This year, Oncidium has a lot to be thankful for! We have been able to start our activities around the promotion of Radiotheranostics. First...

Promising results for prostate cancer response to PRLT

First promising results on a pilot experience suggest that a single course of tandem therapy with low-activity 225Ac-PSMA-617/full-activity 177Lu-PSMA-617 may safely enhance response to...

A dedicated Oncidium’s Ambassador at ALASBIMN 2019

We could not have missed the XXVII Congress of ALASBIMN 2019 in Lima, Peru! Such an important congress at the regional level that brings...

EANM commitment: learning from the UK experience

Patient/public involvement and engagement (PPI/PE) incorporates and integrates individual’s perspectives in the planning and improvement of healthcare services and research: “No matter how complicated...

CONNECT WITH US

5 days ago
Trial begins for Clarity Pharmaceuticals's #breastimaging radiotracer copper-64 SAR-Bombesin. The data emerging from this study will represent a great step forward to progress this product into other #diagnostic & #therapeutic trials in a range of cancers
https://t.co/keSGIwE3hg
6 days ago
Molecular imaging pioneer Sanjiv Sam Gambhir's efforts focused on developing new technologies that could reveal early signs of disease, especially cancer.
https://t.co/iKJYre02nb
2 weeks ago
Another milestone for the #Oncidiumfoundation: 200 registered hospitals.
Thank you to all the #nuclearmedicine experts that registered their treatment center using #Radiotheranostics for #cancercare.
Help patients worldwide by registering your center👇
https://t.co/FciqeOscuT https://t.co/zV5MdUMESO
3 weeks ago
The Sri Venkateswara Institute of Medical Sciences runs a department of #nuclearmedicine & provides high-end #radiotheranostics treatments. It strives to treat people in need thanks to donations made by visitors of the famous temple of this Indian city.
https://t.co/w20nNNAbrU